| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
RIMORPHIN
|
85006-82-2 |
Α因子
|
Α因子;TYR-GLY-GLY-PHE-LEU-ARG-ARG-GLN-PHE-LYS-VAL-VAL-THR: YGGFLRRQFKVVT
|
C74H115N21O17 |
1570.84 | |
|
E 64d
|
88321-09-9 |
阿洛司他丁
|
E-64d,蛋白酶抑制剂;阿洛司他丁;E-64-D(LOXISTATINE);E-64D蛋白酶抑制剂,阿洛司他丁;E-64D蛋白酶抑制剂
|
C17H30N2O5 |
342.43 | |
|
(S)-2-((tert-Butoxycarbonyl)amino)-6-(2,2,2-trifluoroacetamido)hexanoic acid
|
16965-06-3 |
丁氧羰基-羟基化赖氨酸(TFA)
|
丁氧羰基-羟基化赖氨酸(TFA);叔丁氧羰基-羟基化赖氨酸(TFA);N2-[(叔丁氧基)羰基]-N6-(2,2,2-三氟乙酰基)-L-赖氨酸;N^A-BOC-N^E-三氟乙酰基-L-赖氨酸;N-叔丁氧羰基-N'-三氟乙酰基-L-赖氨酸;NΑ-BOC-NΩ-三氟乙酰基-L-赖氨酸;N2-BOC-N6-(2,2-三氟乙酰基)-L-赖氨酸;丁氧羰基-羟基化赖氨酸
|
C13H21F3N2O5 |
342.31 | 605-558-4 |
|
DYNORPHIN A (1-8(
|
75790-53-3 |
DYNORPHIN A (1-8)
|
|
C46H72N14O10 |
981.15 | |
|
Angiotensin (1-7)
|
51833-78-4 |
A779
|
天冬氨酰-精氨酰-缬氨酰-酪氨酰-异亮氨酰-组氨酰-脯氨酸;血管紧张素片断 1-7 乙酸盐 水合物;血管紧张素 (1-7)>98%;A779;血管紧张素 (1-7)
|
C41H62N12O11 |
899 | |
|
NFAT Inhibitor
|
249537-73-3 |
NFAT INHIBITOR
|
NFAT INHIBITOR>98%
|
C75H118N20O22S |
1683.93 | |
|
HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL
|
89105-94-2 |
FIBRINOGEN-BINDING INHIBITOR PEPTIDE
|
|
C50H80N18O16 |
1189.28 | |
|
Angiotensin I (human, mouse, rat)
|
484-42-4 |
ANGIOTENSIN I
|
血管紧张素 1 (人)>98%;人血管紧张素 I;NH2-DRVYIHPFHL-OH;血管紧张素 1
|
C62H89N17O14 |
1296.48 | |
|
PEPTIDE YY, HUMAN
|
118997-30-1 |
多肽YY(人)
|
六元胜肽;六元胜肽;六元胜肽原料;六元胜肽制药用;六元胜肽;六元胜肽;食品级六元胜肽;食品级六元胜肽
|
C194H295N55O57 |
4309.7524 | |
|
LHRH
|
9034-40-6 |
黄体生成素-释放激素
|
戈那瑞林;黄体生成素-释放激素;GLP-HIS-TRP-SER-TYR-GLY-LEU-SER-PRO-GLY-NH2
|
C55H75N17O13 |
1182.29 | 232-895-0 |
|
Physalaemin
|
2507-24-6 |
PHYSALAEMIN
|
PHYSALAEMIN,≥97% ;泡蛙肽;PHYSALAEMIN肽
|
C58H84N14O16S |
1265.44 | |
|
Endothelin-2, human
|
123562-20-9 |
内皮素2
|
内皮素2,≥97.0% ;内皮素2;CYS-SER-CYS-SER-SER-TRP-LEU-ASP-LYS-GLU-CYS-VAL-TYR-PHE-CYS-HIS-LEU-ASP-ILE-ILE-TRP(DISULFIDE BRIDGE:CYS1-CYS15,CYS3-CYS11);CYS-SER-CYS-SER-SER-TRP-LEU-ASP-LYS-GLU-CYS-VAL-TYR-PHE-CYS-HIS-LEU-ASP-ILE-ILE-TRP: CSCSSWLDKECVYFCHLDIIW DISULFIDE BRIDGES CYS1-CYS15,CYS3-CYS11;人内皮素-2
|
C115H160N26O32S4 |
2546.92 | |
|
CALP1
|
145224-99-3 |
CALCIUM-LIKE PEPTIDE
|
|
C40H75N9O10 |
842.08 | |
|
GALANIN, RAT
|
114547-31-8 |
GALANIN (RAT)
|
甘丙肽(兔),≥97% ;GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-PRO-HIS-ALA-ILE-ASP-ASN-HIS-ARG-SER-PHE-SER-ASP-LYS-HIS-GLY-LEU-THR-NH2;GALANIN RATGALANIN;小鼠促生长激素神经肽-(1-29);甘丙肽(兔);小鼠促生长激素神经肽-(1-29)甘丙肽(兔);大鼠GALANIN肽
|
C141H211N43O41 |
3164.45 | |
|
(R)-2-((tert-Butoxycarbonyl)amino)-5-(cyclohexyloxy)-5-oxopentanoic acid
|
133464-27-4 |
(R)-2-((叔丁氧羰基)氨基)-5-(环己氧基)-5-氧戊酸
|
N-[(1,1-二甲基乙氧基)羰基]-D-谷氨酸5-环己基酯;N-[叔丁氧羰基]-D-谷氨酸 5-环己基酯
|
C16H27NO6 |
329.39 | |
|
H-ASN-GLY-ALA-LYS-ALA-LEU-MET-GLY-GLY-HIS-GLY-ALA-THR-LYS-VAL-MET-VAL-GLY-ALA-ALA-ALA-OH
|
150469-23-1 |
PRION PROTEIN (16-126) (HUMAN) (SCRAMBLED)
|
PRION PROTEIN (106-126) (HUMAN) (SCRAMBLED);PRION PROTEIN FRAGMENT 106-126 SCRAMBLED HUMAN;H-ASN-GLY-ALA-LYS-ALA-LEU-MET-GLY-GLY-HIS-GLY-ALA-THR-LYS-VAL-MET-VAL-GLY-ALA-ALA-ALA-OH;ASN-GLY-ALA-LYS-ALA-LEU-MET-GLY-GLY-HIS-GLY-ALA-THR-LYS-VAL-MET-VAL-GLY-ALA-ALA-ALA
|
C80H138N26O24S2 |
||
|
(R)-Benzyl 2-amino-4-methylpentanoate 4-methylbenzenesulfonate
|
17664-93-6 |
D-亮氨酸苄酯对甲苯磺酸盐
|
D-亮氨酸苄酯对甲苯磺酸盐
|
C20H27NO5S |
393.5 | |
|
BOC-(+/-)-CIS-3-AMINOCYCLOHEXANE-1-CARBOXYLIC ACID
|
334932-13-7 |
3-保护的氨基环己甲酸
|
3-保护的氨基环己甲酸;3-(BOC-氨基)环己烷羧酸;3-(BOC-氨基)环己烷羧酸,98+%;3-BOC-氨基环己甲酸;3-叔丁氧羰基氨基环己烷甲酸;N-BOC-3-氨基环己甲酸;3-(BOC-氨基)环己基羧酸;3-(叔丁氧羰基氨基)-1-环己烷羧酸
|
C12H21NO4 |
243.3 | 200-528-9 |
|
H-HIS-SER-ASP-GLY-ILE-PHE-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2
|
137061-48-4 |
腺苷酸环化酶激活肽-38(抗原)
|
腺苷酸环化酶激活肽-38(抗原);腺苷酸环化酶激活肽-38(抗体);HIS-SER-ASP-GLY-ILE-PHE-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2;TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2: YKQRVKNK-NH2;垂体腺苷酸环化酶-活化聚肽;腺苷酸环化酶激活肽-38
|
C203H331N63O53S1 |
4534.26 | |
|
Epidermal Growth Factor Receptor Peptide
|
96249-43-3 |
EGF RECEPTOR (985-996) (HUMAN)
|
|
C61H93N13O23 |
1376.46 |
药智官方微信
药智官方微博
